论文部分内容阅读
目的:分析小剂量多巴胺联合多巴酚丁胺在小儿重症肺炎治疗中的应用价值。方法:研究对象选取本院2015年3月至2016年2月收治的64例重症肺炎患儿,通过随机数字表法将其分为研究组和参比组各32例。参比组患者接受常规的抗感染、止咳、平喘等治疗;研究组患者在这一基础上联合小剂量多巴胺联合多巴酚丁胺进行治疗。对两组患儿的症状改善时间、临床总有效率指标进行观察对比。结果:研究组患儿的呼吸改善时间、肺部啰音消失时间、三凹征改善时间以及住院时间对比参比组差异显著(P<0.05);研究组患儿的总有效率较参比组更高,二者差异同样明显(P<0.05)。结论:小儿重症肺炎在常规治疗基础上配合小剂量多巴胺联合多巴酚丁胺能够促进病情改善、缩短病程,具有较高的应用价值。
Objective: To analyze the value of low dose dopamine combined with dobutamine in children with severe pneumonia. Methods: Sixty-four children with severe pneumonia admitted from March 2015 to February 2016 in our hospital were selected and randomly divided into study group and reference group with 32 cases in each group. Patients in the reference group were treated with conventional anti-infective, cough-relieving and antiasthmatic treatments. Patients in the study group were treated on the basis of low-dose dopamine combined with dobutamine. On the two groups of children with symptoms of improvement time, total clinical efficiency indicators were observed and compared. Results: The improvement time of breath, the disappearance of pulmonary rales, the improvement time of three concave signs and hospital stay in study group were significantly different from those in reference group (P <0.05). The total effective rate in study group was significantly higher than that in control group Higher, the difference between the two equally obvious (P <0.05). Conclusion: Severe pneumonia in children with conventional treatment based on the combination of low-dose dopamine combined with dobutamine can improve the condition, shorten the course of disease, has a high value.